A Toolbox for Microbiome Engineering
cell.com
cell.com
There is still a great deal of work needed to determine which useful small molecule drugs for cellular manufactories to produce, however. I suspect we're moving into a phase of development in which the capacity to deliver small molecules will outstrip the capacity to identify/invent/determine useful ones, as a lot more must be known to produce the drug than to produce the manufactory and delivery mechanism. Hence antibody production as an early target, since those are much more readily categorized.